1
Judi A Bryant, Brad O Buckman, Imadul Islam, Raju Mohan, Michael M Morrissey, Guo Ping Wei, Wei Xu, Shendong Yuan: Platelet adenosine diphosphate receptor antagonists. Schering Aktiengesellschaft, Seed IP Law Group PLLC, March 1, 2005: US06861424 (6 worldwide citation)

Compounds of the following formula (I): where a, b, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing ...


2

3
Ying zi Xu, Shendong Yuan, David Wone, Andrei Konradi: Pyridinone antagonists of alpha-4 integrins. Elan Pharmaceuticals, Foley & Lardner, February 5, 2013: US08367836 (3 worldwide citation)

The present invention provides compounds that are alpha4 integrin antagonists having a structure according to the following formula: or a tautomer, mixture of tautomers, salt or solvate thereof, wherein Cy, ring A, m, n, p, R1, R2, R3, R4, R5 and R6 are defined in the specification. The invention fu ...


4
Damian Arnaiz, Judi Bryant, Yuo Ling Chou, Richard Feldman, Paul Hrvatin, Imadul Islam, Monica Kochanny, Wheeseong Lee, Mark Polokoff, Hongyi Yu, Shendong Yuan: Indolinone derivatives and their use in treating disease-states such as cancer. Schering Aktiengesellschaft, Jacqueline S Larso, Ronald S Hermenau, Berlex, September 12, 2006: US07105563 (2 worldwide citation)

Indolinone derivatives, such as compounds of the formula (I): wherein A, m, n, R1, R2, R3, R5 and R6 are described herein, are disclosed herein as being useful in treating mammal having disease-states alleviated by the inhibition of PDK-1 activity.


5
Brad Buckman, Kumar Emayan, Imadul Islam, Karen May, Judi Bryant, Raju Mohan, Christopher West, Shendong Yuan: Plasma carboxypeptidase B inhibitors. Schering Aktiengesellshaft, Millen White Zelano & Branigan P C, May 5, 2009: US07528173 (1 worldwide citation)

Compounds of the following formula (I), for example: (1), wherein R1, R2, R3, and R4 are described herein, are useful as inhibitors of plasma carboxypeptidase B. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthe ...


6
Marc Adler, Stefan Baeurle, Judi Bryant, Ming Chen, Yuo Ling Chou, Paul Hrvatin, Seock Kyu Khim, Monica Kochanny, Wheeseong Lee, Michael Mamounas, Janet Meurer Ogden, Gary Bruce Phillips, Victor Selchau, Christopher West, Bin Ye, Shendong Yuan, Martin Krueger: Dihydropyridine derivatives as useful as protein kinase inhibitors. Bayer Intellectual Property, June 12, 2012: US08198456 (1 worldwide citation)

This invention provides novel dihydropyridine derivatives of the formula I having protein tyrosine kinase inhibitory activity, to process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions.


7
Judi A Bryant, Brad O Buckman, Imadul Islam, Raju Mohan, Michael M Morrissey, Guo Ping Wei, Wei Xu, Shendong Yuan: Platelet adenosine diphosphate receptor antagonists. Schering Aktiengesellschaft, Seed IP Law Group PLLC, February 7, 2006: US06995156 (1 worldwide citation)

Compounds of the following formula (I): where a, b, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing ...


8
Judi A Bryant, Brad O Buckman, Imadul Islam, Raju Mohan, Michael M Morrissey, Guo Ping Wei, Wei Xu, Shendong Yuan: Platelet adenosine diphosphate receptor antagonists. Schering Aktiengesellschaft, Seed IP Law Group PLLC, April 11, 2006: US07026323 (1 worldwide citation)

Compounds of the following formula (I): where a, b, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing ...


9
Brad O Buckman, Kumar Emayan, Imadul Islam, Karen May, Judi Bryant, Raju Mohan, Christopher West, Shendong Yuan: Plasma carboxypeptidase B inhibitors. Bayer Schering Pharma, Millen White Zelano & Branigan P C, August 30, 2011: US08008325

Compounds of the following formula (I), for example: wherein R1, R2, R3, and R4 are described herein, are useful as inhibitors of plasma carboxypeptidase B. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizin ...


10
Ying Zi Xu, Dean R Artis, Simeon Bowers, Roy K Hom, Hing L Sham, Shendong Yuan: Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof. Imago Pharmaceuticals, Oblon McClelland Maier & Neustadt L, November 15, 2016: US09493485

Compounds are provided having a structure according to Formula (I): wherein A1, A2, A3, Y, R1, R2, R3, R4, R5, R6, m, n and p are defined herein. Further provided are pharmaceutical compositions including the compounds provided and methods of making and using the compounds and compositions as provid ...